$MEIP..Older Upgrades worth noting: Roth Capital Keeps Buy On MEI Pharma Following Company’s Release Of F2014 Results http://t.co/G2yKf0pLot MEI Pharma Research Coverage Started at Cantor Fitzgerald $MEIP http://t.co/yDXdhstWHV